Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)DivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsSales of Property, Plant and EquipmentShare-based CompensationShares IssuedShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Roivant Sciences (ROIV) Net Cash Flow: 2021-2025

Historic Net Cash Flow for Roivant Sciences (ROIV) over the last 5 years, with Mar 2025 value amounting to -$3.8 billion.

  • Roivant Sciences' Net Cash Flow rose 99.93% to -$2.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$9.7 billion, marking a year-over-year decrease of 2289.71%. This contributed to the annual value of -$3.8 billion for FY2025, which is 178.75% down from last year.
  • According to the latest figures from FY2025, Roivant Sciences' Net Cash Flow is -$3.8 billion, which was down 178.75% from $4.9 billion recorded in FY2024.
  • Over the past 5 years, Roivant Sciences' Net Cash Flow peaked at $4.9 billion during FY2024, and registered a low of -$3.8 billion during FY2025.
  • Its 3-year average for Net Cash Flow is $214.7 million, with a median of -$388.2 million in 2023.
  • In the last 5 years, Roivant Sciences' Net Cash Flow plummeted by 473.90% in 2023 and then spiked by 1,351.34% in 2024.
  • Yearly analysis of 5 years shows Roivant Sciences' Net Cash Flow stood at -$127.6 million in 2021, then soared by 46.98% to -$67.6 million in 2022, then tumbled by 473.90% to -$388.2 million in 2023, then skyrocketed by 1,351.34% to $4.9 billion in 2024, then plummeted by 178.75% to -$3.8 billion in 2025.